Literature DB >> 16371354

Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor.

Mathew A von Wronski1, Natarajan Raju, Radhakrishna Pillai, Nancy J Bogdan, Edmund R Marinelli, Palaniappa Nanjappan, Kondareddiar Ramalingam, Thangavel Arunachalam, Steve Eaton, Karen E Linder, Feng Yan, Sibylle Pochon, Michael F Tweedle, Adrian D Nunn.   

Abstract

Tuftsin, Thr-Lys-Pro-Arg (TKPR), is an immunostimulatory peptide with reported nervous system effects as well. We unexpectedly found that tuftsin and a higher affinity antagonist, TKPPR, bind selectively to neuropilin-1 and block vascular endothelial growth factor (VEGF) binding to that receptor. Dimeric and tetrameric forms of TKPPR had greatly increased affinity for neuropilin-1 based on competition binding experiments. On endothelial cells tetrameric TKPPR inhibited the VEGF(165)-induced autophosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) even though it did not directly inhibit VEGF binding to VEGFR-2. Homology between exon 8 of VEGF and TKPPR suggests that the sequence coded for by exon 8 may stabilize VEGF binding to neuropilin-1 to facilitate signaling through VEGFR-2. Given the overlap between processes involving neuropilin-1 and tuftsin, we propose that at least some of the previously reported effects of tuftsin are mediated through neuropilin-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371354     DOI: 10.1074/jbc.M511941200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Authors:  Matthew W Parker; Ping Xu; Xiaobo Li; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization.

Authors:  Irina Vetter; Wei Cheng; Madusha Peiris; Bruce D Wyse; Sarah J Roberts-Thomson; Jie Zheng; Gregory R Monteith; Peter J Cabot
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

4.  Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.

Authors:  Matthew W Parker; Lance M Hellman; Ping Xu; Michael G Fried; Craig W Vander Kooi
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

5.  Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.

Authors:  Matthew W Parker; Andrew D Linkugel; Hira Lal Goel; Tingting Wu; Arthur M Mercurio; Craig W Vander Kooi
Journal:  Structure       Date:  2015-03-05       Impact factor: 5.006

6.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

7.  HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Authors:  Sophie Lambert; Manuella Bouttier; Roger Vassy; Michel Seigneuret; Cari Petrow-Sadowski; Sébastien Janvier; Nikolaus Heveker; Francis W Ruscetti; Gérard Perret; Kathryn S Jones; Claudine Pique
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

8.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 9.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

10.  Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1.

Authors:  Matthew W Parker; Andrew D Linkugel; Craig W Vander Kooi
Journal:  J Mol Biol       Date:  2013-07-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.